The cost of stem cell transplantation for hyperglycemia is not good to give a clear value, because everyone's condition is different, and everyone's plan is also different. In addition, the charging standards of different hospital levels are also slightly different, and you can choose the right hospital according to your condition.
At present, the most commonly used means of hyperglycemia are oral hypoglycemic drugs and external injection of insulin, or exercise and diet, which have certain limitations, that is, they only control blood sugar levels on the surface, but cannot correct the fat and protein metabolism that is still in a disordered state. How to rebuild the endogenous insulin secretion system is the root cause of hyperglycemia.
What are human pluripotent stem cells**?
Human pluripotent stem cells have the potential to proliferate and differentiate into functional cells indefinitely, which makes the use of human pluripotent stem cells** functional cells promising to be used for a variety of major diseases**.
At present, there are mature technical solutions and good clinical effects for clinical islet transplantation**hyperglycemia, but the scarcity of human pancreatic donors greatly limits its wide application.
Pancreatic islet cells prepared from human pluripotent stem cells are expected to break through this bottleneck, which is the fastest possible breakthrough direction for human pluripotent stem cells in the field of translational medicine.
According to Professor Wang Shusen of the Organ Transplantation Center of Tianjin First Central Hospital, preclinical primate experiments are an important early basis for the clinical research of islet transplantation of IPS**, which can better evaluate the safety and effectiveness of the first-class regimen, and has very important guiding significance for the smooth implementation of follow-up clinical research.
The team will continue to optimize the differentiation and transplantation scheme of IPS to islets, and systematically carry out clinical research on islet transplantation of IPS**, and strive to benefit the majority of patients with type 1 hyperglycemia as soon as possible.
Hyperglycemia** has become a major public health challenge, with more than 600 million people expected to suffer from hyperglycemia by 2040. Traditional hypoglycemic drugs and insulin injections do not hyperglycemia, and the quality of life of patients cannot be completely improved.
Advantages of Stem Cell** hyperglycemia.
Compared with the traditional method of hyperglycemia, stem cells use mesenchymal stem cells to repair their own pancreatic islet function and improve the symptoms of hyperglycemia. After stem cells**, about 65% of patients are free from dependence on insulin or oral medications; More than 90% of patients have reduced the dose of insulin or oral medication, or switched from insulin injection to oral medication**, which greatly controls or slows the occurrence and progression of complications.
The clinical efficacy and safety of hyperglycemic stem cells** have been proven, and they are a simple, safe, and effective method. For complications such as hyperglycemic myocardial damage, hyperglycemic foot, hyperglycemic retinopathy, hyperglycemic nephropathy, and erectile dysfunction, stem cells also have the best effect. It is expected that in the near future, this scientific and technological achievement will bring new hope to more hyperglycemia patients**.